Opioid use in patients recovering from hip and knee replacement decreased by one-third between 2006 and 2014, reflecting success in efforts to promote a multimodal approach to pain management (using a variety of methods to manage pain) rather than using opioids alone, reveals new research being presented at the ANESTHESIOLOGY® 2017 annual meeting.
Morbidly obese patients who underwent aseptic revision total hip arthroplasty experienced similar complications, failures and clinical outcomes compared with nonobese patients, according to study results.
The authors are from the Philadelphia College of Osteopathic Medicine (JMB, JJC), Philadelphia, Pennsylvania; the Rubin Institute for Advanced Orthopedics (JBM, RKE), Center for Joint Preservation and Replacement, Sinai Hospital of Baltimore, Baltimore, Maryland; the Department of Orthopaedic Surgery (MC, MAM), Cleveland Clinic, Cleveland, Ohio; and the Adult Reconstruction Service (SFH), Mount Sinai Beth Israel, New York, New York.
According to a new literature review in the February issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), a team-based care approach (consisting of the patient, family members, the orthopaedic surgeon and other medical practitioners) on total knee replacement (TKR) procedures, in conjunction with newer pain management strategies, is key to maximizing patient outcomes.
Smokers who needed a hip or knee replacement experienced better surgical outcomes and fewer adverse events including hospital readmissions, surgical site infections and blood clots if they were enrolled in a smoking cessation program prior to surgery, according to preliminary new research that needs to be confirmed by larger studies.